Home › Funds › Two Sigma Investments › ASTH
Two Sigma Investments position in ASTH
ASTRANA HEALTH INC · Consumer Discretionary
Latest position (Q4 2025)30.71K sh
Reported value held$761.99K
Portfolio Weight0.00%
First reportedQ1 2022
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 32.94K | $1.60M | New |
| Q4 2022 | 7.30K | $216.01K | New |
| Q1 2023 | 11.10K | $404.82K | Add |
| Q2 2023 | 11.10K | $350.76K | Hold |
| Q3 2023 | 11.10K | $342.44K | Hold |
| Q4 2023 | 11.10K | $425.13K | Hold |
| Q4 2024 | 14.79K | $466.42K | New |
| Q4 2025 | 30.71K | $761.99K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ASTH
- BlackRock Inc 6.90M sh · $320.23M · Q2 2026
- Vanguard Group 4.24M sh · $105.15M · Q4 2025
- Wellington Management Group 1.29M sh · $59.99M · Q2 2026
- Geode Capital Management 1.17M sh · $54.22M · Q2 2026
- Bank of America Corp 852.14K sh · $39.55M · Q2 2026
- Fidelity Management & Research (FMR) 685.92K sh · $31.83M · Q2 2026
- Wells Fargo & Co 664.94K sh · $30.86M · Q2 2026
- Charles Schwab Investment Management 652.67K sh · $30.29M · Q2 2026
- Northern Trust Corp 505.04K sh · $23.44M · Q2 2026
- Royce & Associates 472.48K sh · $21.93M · Q2 2026
- Morgan Stanley 433.51K sh · $20.12M · Q2 2026
- Invesco Ltd 381.83K sh · $17.72M · Q2 2026